Causes and Consequences of Acid pH in Tumors
Causes and Consequences of Acid pH in Tumors
批准号:
7413488
负责人:
Robert J. Gillies
金额:
$12.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2008-04-30
关键词:
AcidityAcidsAerobicAlkalinizationAlkalosisAreaBehaviorBenignBiochemicalBooksBreast Cancer CellCell LineCellsClassClinicClinical TrialsContrast MediaCoupledDepthDevelopmentDisseminated Malignant NeoplasmEndopeptidasesEvolutionExtravasationFundingGadoliniumGd-DOTA-4amPGlycolysisHumanHypoxiaHypoxia Inducible FactorImageImidazoleInjection of therapeutic agentLettersLiteratureMalignant - descriptorMalignant NeoplasmsManuscriptsMeasurementMeasuresMetabolicMetastatic toMethodsModelingNeoplasm MetastasisOxygenPeptide HydrolasesPerfusionPharmaceutical PreparationsPhenotypePrimary LesionProcessPublishingReporterResearchResistanceResolutionResponse ElementsSystemTestingTissuesTumor OxygenationWorkaerobic glycolysisbasechemotherapydesignextracellularimprovedmethod developmentneoplastic cellnovelpressureprogramsresearch studytumortumor progressionuptake
中文摘要
肿瘤的微环境可能是一个充满敌意的地方,有明显的缺氧和酸性区域。
这项研究计划的重点是肿瘤的pH值,虽然肿瘤氧合的研究也是
包括.寻求更新资金以继续改进肿瘤pH成像方法(目标1),and.to
了解在这种恶劣的微环境中酸堆的原因(目标2)和后果(目标3)。
在上一个支持期间,我们在所有三个目标方面都取得了重大进展。新的方法已经
发展和输出,有氧糖酵解和高酸中毒之间的基本关系,
暴露,并在赋予耐电离药物的酸桩的效果进行了表征。从
根据这些最后的发现,正在计划一项临床试验,以提高米托蒽醌治疗的疗效,
代谢碱化一本书和27份手稿已经出版,正在印刷或已经出版。
已提交。
在下一个支持期的目标1中,我们建议开发一种令人兴奋的新型MRI敏感
含Gd的pH报告者,其有望以非常高的时空分辨率成像pH。一
将花费大量的精力来开发最终适用于
诊所目标2和3的实验将集中在测试一种新的模型,该模型治疗缺氧和酸性,
肿瘤作为选择性压力,驱动肿瘤表型从良性到转移性的演变。的
模型提出,短暂缺氧-
缺氧反应元件,HIF-la _有氧糖酵解_胃酸过多_蛋白酶--_外渗
殖民地时期的生存。这些联系中的每一个都在文献中被观察到,但没有
在单一系统中测试。这种模型可以解释为什么氟脱氧葡萄糖的摄取增加,
常见于转移性癌症。目标2将确定是否存在功能连接,
HIF-1或,升高的有氧糖酵解,转移潜能和高酸性堆在肿瘤中使用原发性和
建立了人类乳腺癌细胞目标3将确定是否存在功能连接,
糖酵解、酸堆和转移在外渗和定植水平。尽管特定
假设将被测试,实验的目的是产生重要的信息,即使假设是
不是这样的
英文摘要
The microenvironment of tumors can be a hostile place, with significant regions that are hypoxic and acidic.
The focus of this research program is on the tumor pH, although studies of tumor oxygenation are also
included. Renewal funding is sought to continue improving methods for imaging tumor pH (Aim 1), and.to
understand the causes (Aim 2) and consequences (Aim 3) of acid pile in this hostile microenvironment.
During the last period of support we made significant advances in all three aims. New methods have been
developed and exported, a fundamental relationship between aerobic glycolysis and hyperacidosis was
uncovered, and the effect of acid pile in conferring resistance to ionizable drugs was characterized. From
these last findings, a clinical trial is being planned to enhance the efficacy ofmitoxantrone therapy with
metabolic alkalinization. One book and 27 manuscripts have been published, are in press or have been
submitted.
In Aim 1 of the next period of support, we propose to develop an exciting new class of MRI-sensitive
Gd-containing pH reporters which hold promise for imaging pH with very high spatio-temporal resolution. A
significant effort will be spent developing quantitative methods that would eventually be appropriate for the
clinic. Experiments in aims 2 & 3 will focus on testing a novel model which treats the hypoxia and acidity in
tumors as selective pressures that drive the evolution of the tumor phenotype from benign to metastatic. The
model proposes that there are functional connections between transient hypoxia --_ dysregulation of the
hypoxia response element, HIF-la _ aerobic glycolysis _ hyperacidity _ proteases --_ extravasation
survival during colonization. Each of these connections has been observed in the literature, but has not
been tested in a single system. Such a model could explain why elevated uptake of flurodeoxyglucose is
commonly observed in metastatic cancers. Aim 2 will determine if there are functional connections between
HIF-1 or, elevated aerobic glycolysis, metastatic potential and hyperacidic pile in tumors using primary and
established human breast cancer cells. Aim 3 will determine if there are functional connections between
glycolysis, acid pile and metastasis at the levels of extravasation and colonization. Although specific
hypotheses will be tested, experiments are designed to yield important information even if the hypotheses are
not true.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imaging Acidosis and Immune Therapy in PDAC
-
批准号:10088425
-
项目类别:
-
资助金额:$68.35万
-
财政年份:2020
-
负责人:Robert J. Gillies
-
依托单位:
Imaging Acidosis and Immune Therapy in PDAC
-
批准号:9896558
-
项目类别:
-
资助金额:$68.35万
-
财政年份:2020
-
负责人:Robert J. Gillies
-
依托单位:
Imaging Habitats in Sarcoma
-
批准号:9461334
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2017
-
负责人:Robert J. Gillies
-
依托单位:
Moffitt Imaging Biomarker VAlidation Center
-
批准号:8996954
-
项目类别:
-
资助金额:$70.7万
-
财政年份:2016
-
负责人:Robert J. Gillies
-
依托单位:
Moffitt Imaging Biomarker VAlidation Center
-
批准号:9906855
-
项目类别:
-
资助金额:$87.93万
-
财政年份:2016
-
负责人:Robert J. Gillies
-
依托单位:
Moffitt Imaging Biomarker VAlidation Center
-
批准号:10376917
-
项目类别:
-
资助金额:$46.76万
-
财政年份:2016
-
负责人:Robert J. Gillies
-
依托单位:
Moffitt Imaging Biomarker VAlidation Center
-
批准号:9304110
-
项目类别:
-
资助金额:$71.7万
-
财政年份:2016
-
负责人:Robert J. Gillies
-
依托单位:
Imaging Habitats in Sarcoma
-
批准号:9047257
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2015
-
负责人:Robert J. Gillies
-
依托单位:
Imaging Habitats in Sarcoma
-
批准号:8892622
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2015
-
负责人:Robert J. Gillies
-
依托单位:
(PQC4) Habitats in Prostate Cancer
-
批准号:8930109
-
项目类别:
-
资助金额:$69.2万
-
财政年份:2014
-
负责人:Robert J. Gillies
-
依托单位:
Molecular-Lab Radiopharmaceutical Synthesis System
-
批准号:8640558
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2014
-
负责人:Robert J. Gillies
-
依托单位:
Radiomics of NSCLC
-
批准号:9753940
-
项目类别:
-
资助金额:$56.89万
-
财政年份:2010
-
负责人:Robert J. Gillies
-
依托单位:
Radiomics of NSCLC
-
批准号:9104812
-
项目类别:
-
资助金额:$56.27万
-
财政年份:2010
-
负责人:Robert J. Gillies
-
依托单位:
The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and Metastase
-
批准号:8555188
-
项目类别:
-
资助金额:$60.12万
-
财政年份:2009
-
负责人:Robert J. Gillies
-
依托单位:
Targeting Pancreatic Cancer
-
批准号:7266503
-
项目类别:
-
资助金额:$54.58万
-
财政年份:2007
-
负责人:Robert J. Gillies
-
依托单位:
Targeting Pancreatic Cancer
-
批准号:7679102
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2007
-
负责人:Robert J. Gillies
-
依托单位:
Targeting Pancreatic Cancer
-
批准号:7500793
-
项目类别:
-
资助金额:$50.06万
-
财政年份:2007
-
负责人:Robert J. Gillies
-
依托单位:
Targeting Pancreatic Cancer
-
批准号:7916650
-
项目类别:
-
资助金额:$65.93万
-
财政年份:2007
-
负责人:Robert J. Gillies
-
依托单位:
MRI IMAGING OF TUMOR HYPOXIA
-
批准号:7302125
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2007
-
负责人:Robert J. Gillies
-
依托单位:
Multimeric Ligands for Targeting of Melanoma
-
批准号:7048693
-
项目类别:
-
资助金额:$57.86万
-
财政年份:2003
-
负责人:Robert J. Gillies
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: